Conduct a financial analysis of the company. Provide at least five important measures of the companys financial
Question:
Conduct a financial analysis of the company. Provide at least five important measures of the company’s financial well-being
For each of these measures, explain:
a. In layman’s terms what the financial measure means and why it is an important measure for determining your chosen company’s prospects for successful growth
b. What the value of this figure says about the financial well-being of your chosen company
c. How the value of that measure compares to at least one of the following
i. The industry average
ii. At least one of your company’s competitors or
iii. A similar or related company
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Income Statement [Abstract] | ||||
Revenues | $ 60,808 | $ 57,616 | $ 116,487 | $ 113,344 |
Cost of sales | (57,808) | (54,749) | (110,787) | (107,690) |
Gross profit | 3,000 | 2,867 | 5,700 | 5,654 |
Operating expenses | (2,237) | (2,196) | (4,203) | (4,326) |
Goodwill impairment charges | (69) | 0 | (69) | 0 |
Restructuring, impairment, and related charges | (60) | (45) | (116) | (68) |
Total operating expenses | (2,366) | (2,241) | (4,388) | (4,394) |
Operating income | 634 | 626 | 1,312 | 1,260 |
Other income (expense), net | 71 | (78) | 98 | (41) |
Equity earnings and charges from investment in Change Healthcare Joint Venture | 0 | (1,454) | 0 | (1,450) |
Interest expense | (50) | (64) | (110) | (120) |
Income (loss) from continuing operations before income taxes | 655 | (970) | 1,300 | (351) |
Income tax benefit (expense) | (28) | 294 | (178) | 158 |
Income (loss) from continuing operations | 627 | (676) | 1,122 | (193) |
Loss from discontinued operations, net of tax | 0 | (1) | (1) | (7) |
Net income (loss) | 627 | (677) | 1,121 | (200) |
Net income attributable to noncontrolling interests | (50) | (53) | (100) | (107) |
Net income (loss) attributable to McKesson Corporation | $ 577 | $ (730) | $ 1,021 | $ (307) |
Diluted | ||||
Continuing operations (in dollars per share) | $ 3.54 | $ (3.99) | $ 6.26 | $ (1.62) |
Discontinued operations (in dollars per share) | 0 | 0 | 0 | (0.03) |
Total (in dollars per share) | 3.54 | (3.99) | 6.26 | (1.65) |
Basic | ||||
Continuing operations (in dollars per share) | 3.56 | (3.99) | 6.31 | (1.62) |
Discontinued operations (in dollars per share) | 0 | 0 | (0.01) | (0.03) |
Total (in dollars per share) | $ 3.56 | $ (3.99) | $ 6.30 | $ (1.65) |
Weighted-average common shares outstanding | ||||
Diluted (in shares) | 163 | 183 | 163 | 185 |
Basic (in shares) | 162 | 183 | 162 | 185 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) | Sep. 30, 2020 | Mar. 31, 2020 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 3,091 | $ 4,015 |
Receivables, net | 19,285 | 19,950 |
Inventories, net | 18,435 | 16,734 |
Assets held for sale | 833 | 906 |
Prepaid expenses and other | 701 | 617 |
Total current assets | 42,345 | 42,222 |
Property, plant, and equipment, net | 2,471 | 2,365 |
Operating lease right-of-use assets | 1,895 | 1,886 |
Goodwill | 9,414 | 9,360 |
Intangible assets, net | 3,030 | 3,156 |
Other non-current assets | 2,403 | 2,258 |
Total assets | 61,558 | 61,247 |
Current liabilities | ||
Drafts and accounts payable | 36,255 | 37,195 |
Current portion of long-term debt | 1,760 | 1,052 |
Current portion of operating lease liabilities | 367 | 354 |
Liabilities held for sale | 537 | 683 |
Other accrued liabilities | 3,805 | 3,340 |
Total current liabilities | 42,724 | 42,624 |
Long-term debt | 5,848 | 6,335 |
Long-term deferred tax liabilities | 2,293 | 2,255 |
Long-term operating lease liabilities | 1,669 | 1,660 |
Other non-current liabilities | 1,669 | 1,662 |
Redeemable noncontrolling interests | 1,265 | 1,402 |
McKesson Corporation stockholders’ equity | ||
Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding | 0 | 0 |
Common stock, $0.01 par value, 800 shares authorized, and 273 and 272 shares issued at September 30, 2020, and March 31, 2020, respectively | 2 | 2 |
Additional paid-in capital | 6,780 | 6,663 |
Retained earnings | 13,890 | 13,022 |
Accumulated other comprehensive loss | (1,597) | (1,703) |
Treasury shares, at cost, 112 and 110 shares at September 30, 2020, and March 31, 2020, respectively | (13,185) | (12,892) |
Total McKesson Corporation stockholders’ equity | 5,890 | 5,092 |
Noncontrolling interests | 200 | 217 |
Total equity | 6,090 | 5,309 |
Total liabilities, redeemable noncontrolling interests, and equity | $ 61,558 | $ 61,247 |
Financial Reporting and Analysis Using Financial Accounting Information
ISBN: 978-1439080603
12th Edition
Authors: Charles H Gibson